AVASOPASEM
(4S,9S,14S,19S)-3,10,13,20,26-pentazatetracyclo[20.3.1.04,9.014,19]hexacosa-1(26),22,24-triene
Molecular Identity
AVASOPASEM
(4S,9S,14S,19S)-3,10,13,20,26-pentazatetracyclo[20.3.1.04,9.014,19]hexacosa-1(26),22,24-triene
PubChem CID: 11640916
2D Structure
Properties
C21H35N5
Molecular Formula
357.50
Molecular Weight
g/mol
357.2892
Exact Mass
Da
1.2
XLogP
Drug-like (Lipinski: < 5)
61
TPSA
Good oral absorption (< 140 A²)
4
H-Bond Donors
5
H-Bond Acceptors
381
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(4)
AVASOPASEMHP219O4H4VSCHEMBL25461006(4AS,13AS,17AS,21AS)-1,2,3,4,4A,5,6,12,13,13A,14,15,16,17,17A,18,19,20,21,21A-EICOSAHYDRO-11,7-NITRILO-7H-DIBENZO(B,H)(1,4,7,10)TETRAAZACYCLOHEPTADECINE
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to AVASOPASEM
Loading drug network...